Catalent Bolsters Clinical Supply Capabilities
Catalent Pharma Solutions has completed a $5.5 million expansion program at its more than 200,000 square foot Philadelphia, PA, site to provide additional clinical packaging and storage capacity.
The facility, which is located near many customers and major transportation hubs, is also one of the largest sites in Catalent's global clinical supply network. The investment has provided the site with a 40% increase in pallet space for both refrigerated and ambient clinical storage, additional cold chain packaging areas, and a new clinical label control area. The building also features a new campus-wide environmental monitoring and building management system.
"The expansion not only allows us to meet the demand for additional capacity to serve large-scale clinical studies today, but also provides the space necessary for future growth," said Albert Quintero, general manager, clinical supply services, Catalent. "We look forward to welcoming new and existing customers at these new facilities."
With sites in the U.S., UK, Germany, Japan and China, and an extended network of over 50 depots, Catalent's clinical supply services team has the capability and expertise to handle a broad range of international compliance and distribution requirements, and so help to expedite clinical trials by ensuring customers are reliably supplied where and when needed around the globe.
Looking for chemical products? Let suppliers reach out to you!
2026-07-21
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Pharma Quality Excellence Awards 2026 - Celebration and Conclusion
-
Pharma Quality Reimagined: Highlights from the 6th Annual Pharma GMP & Quality Management 2026
-
From Feedmill to Food System: VIV Europe 2026 Addresses the Industry's Most Critical Challenges
-
Beyond Compliance: Building Quality Maturity
-
Catalent Faces Continuous Losses and Operational Challenges in 2023, Reports $715 Million Net Loss in Q1 2024
-
Is the class solidified? From Biotech to Pharma
-
The IPO of the Largest Domestic Metronidazole API Manufacturer has Passed the Meeting
-
Progesterone Market Potential is Huge
-
PharmaReg AfriSummit
-
2022 PHARMA X FOOD X FINE CHEMICAL RAW MATERIALS MATCH MEETING Successfully Held!
Recommend Reading
-
Sun Pharma’s Ilumya Hits Primary Endpoint in Two Phase 3 Trials for Psoriatic Arthritis $681 Million Drug Shows Significant Improvement at Week 24
-
Novo Nordisk Reports Theft of Six Drug Batches in India Authorities Warn of Severe Patient Safety Risks
-
Bristol Myers’ Reblozyl Misses Main Goal in Cancer Anemia Study $1.77 Billion Drug Faces Setback but Shows Some Benefits
-
Sanofi’s $2.2 Billion Dynavax Acquisition: Why Big Pharma Is Rebuilding the Global Vaccine Order
-
Glenmark Recalls Over 110000 Bottles of BP and COPD Drugs in US Due to Safety Concerns
-
Polyethylene prices reduced, short-term weak operation
-
Both Cost and Demand Weaken, PTA Prices Fluctuate and Decline in May
-
Double Negative Impact on Costs and Demand—Polyester Staple Fiber Prices Shift Lower in May
-
Polyethylene Market Continues to Show Weakness
-
In May, China's acetone market shows weak supply and demand, leading to a downward trend